Oncology & Cancer

Experts address the latest advances in cervical cancer treatment

Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer mortality among women ...

Obstetrics & gynaecology

Could the Pap smear be ousted by HPV testing?

A Pleasanton firm that received FDA approval for a test against cervical cancer said it has gained the support of a panel of medical experts to use the test as a frontline screening for women as young as 25, but the announcement ...

Oncology & Cancer

One in 10 US women miss cervical cancer screenings

Eight million US women have not been screened in the last five years for cervical cancer, even though regular checkups can help prevent the fatal disease, US health authorities said Wednesday.

Oncology & Cancer

Cancer-screening software wins wireless competition

A software program for screening for cervical cancer, particularly in developing countries with limited resources, earned the top award and $10,000 in the Qualcomm Wireless Innovation Prize at UW-Madison. The AlgoCerv software ...

Oncology & Cancer

DNA alternative to Pap smear sparks medical debate (Update)

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen American patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: ...

Oncology & Cancer

Swedish model for PSA testing has little effect on mortality

The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk ...

page 7 from 10